{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:04:37Z","timestamp":1777539877022,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Bristol-Myers Squibb Pharmaceuticals Limited"},{"name":"Otsuka Pharmaceuticals Limited"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.schres.2015.12.007","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T06:00:17Z","timestamp":1452578417000},"page":"245-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5443-4443","authenticated-orcid":false,"given":"Rohit J.","family":"Lodhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salaj","family":"Masand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuppuswami","family":"Shivakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria D.M.","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"O'Keane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah C.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian H.","family":"Heald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy A.","family":"Sherwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine J.","family":"Aitchison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2015.12.007_bb0005","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.4088\/JCP.v69n0907","article-title":"Sex- and age-specific incidence of fractures in mental illness: a historical, population-based cohort study","volume":"69","author":"Abel","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2015.12.007_bb0010","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0269881109358198","article-title":"Costs and outcomes associated with an aripiprazole add-on or switching open-label study in psychosis","volume":"25","author":"Aitchison","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2015.12.007_bb0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.12.007_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/2045125312442080","article-title":"Risperidone-associated prolactin elevation and markers of bone turnover during acute treatment","volume":"2","author":"Bishop","year":"2012","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.schres.2015.12.007_bb0025","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-011-1545-x","article-title":"Non-pharmacological management of osteoporosis: a consensus of the Belgian bone club","volume":"22","author":"Body","year":"2011","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.schres.2015.12.007_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/JCP.0b013e3182075587","article-title":"Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women","volume":"31","author":"Bolton","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"421","key":"10.1016\/j.schres.2015.12.007_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/01621459.1993.10594284","article-title":"Approximate inference in generalized linear mixed models","volume":"88","author":"Breslow","year":"1993","journal-title":"J. Am. Stat. Assoc."},{"issue":"4","key":"10.1016\/j.schres.2015.12.007_bb0040","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-002-1344-3","article-title":"Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study","volume":"166","author":"Casey","year":"2003","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.schres.2015.12.007_bb0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/11208400-000000000-00000","article-title":"Aripiprazole: a review of its use in the management of schizophrenia in adults","volume":"26","author":"Croxtall","year":"2012","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.schres.2015.12.007_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2015.12.007_bb0060","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1139\/H08-033","article-title":"Associations of oral contraceptive use and dietary restraint with bone speed of sound and bone turnover in university-aged women","volume":"33","author":"Di Giovanni","year":"2008","journal-title":"Appl. Physiol. Nutr. Metab."},{"issue":"9","key":"10.1016\/j.schres.2015.12.007_bb0065","doi-asserted-by":"crossref","first-page":"E1732","DOI":"10.1210\/jc.2014-2288","article-title":"Effects of escitalopram on markers of bone turnover: a randomized clinical trial","volume":"99","author":"Diem","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.schres.2015.12.007_bb0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bone.2007.12.218","article-title":"Establishing a reference range for bone turnover markers in young, healthy women","volume":"42","author":"Glover","year":"2008","journal-title":"Bone"},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2015.12.007_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0306-4530(02)00112-9","article-title":"Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2015.12.007_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.bp.106.023671","article-title":"Risk of hip fracture in patients with a history of schizophrenia","volume":"190","author":"Howard","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.12.007_bb0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1176\/appi.ajp.162.1.162","article-title":"Osteoporosis in patients with schizophrenia","volume":"162","author":"Hummer","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2015.12.007_bb0095","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/clinchem\/43.9.1570","article-title":"Comparison of analytical performance and biological variability of three bone resorption assays","volume":"43","author":"Ju","year":"1997","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.schres.2015.12.007_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3371\/CSRP.KISE.020113","article-title":"Bone loss associated with hyperprolactinemia in patients with schizophrenia","volume":"7","author":"Kinon","year":"2013","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"5","key":"10.1016\/j.schres.2015.12.007_bb0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/YCO.0b013e328355e1ac","article-title":"Osteoporosis and fracture risk in people with schizophrenia","volume":"25","author":"Kishimoto","year":"2012","journal-title":"Curr. Opin. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2015.12.007_bb0115","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","article-title":"Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes","volume":"20","author":"Lawler","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.schres.2015.12.007_bb0120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4306\/pi.2010.7.4.278","article-title":"Bone density in chronic schizophrenia with long-term antipsychotic treatment: preliminary study","volume":"7","author":"Lee","year":"2010","journal-title":"Psychiatry Investig."},{"issue":"5","key":"10.1016\/j.schres.2015.12.007_bb0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0447.2007.01095.x","article-title":"Physical illness and schizophrenia: a review of the literature","volume":"116","author":"Leucht","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.schres.2015.12.007_bb0130","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/schbul\/sbv037","article-title":"Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method","volume":"41","author":"Leucht","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2015.12.007_bb0140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1192\/bjp.184.6.503","article-title":"Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia","volume":"184","author":"Meaney","year":"2004","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.12.007_bb0145","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0269881107082901","article-title":"Change in sexual dysfunction with aripiprazole: a switching or add-on study","volume":"22","author":"Mir","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.schres.2015.12.007_bb0150","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.4088\/JCP.v65n1205","article-title":"Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism","volume":"65","author":"Misra","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.12.007_bb0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.jcp.0000150223.31007.e0","article-title":"Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?","volume":"25","author":"O'Keane","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.12.007_bb0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.schres.2013.06.030","article-title":"How to compare doses of different antipsychotics: a systematic review of methods","volume":"149","author":"Patel","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.12.007_bb0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2474-11-35","article-title":"Effects of plasma magnesium and prolactin on quantitative ultrasound measurements of heel bone among schizophrenic patients","volume":"11","author":"Renn","year":"2010","journal-title":"BMC Musculoskelet. Disord."},{"issue":"1","key":"10.1016\/j.schres.2015.12.007_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hup.984","article-title":"Ultrasound bone mass in schizophrenic patients on antipsychotic therapy","volume":"24","author":"Rey-Sanchez","year":"2009","journal-title":"Hum. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2015.12.007_bb0175","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00198-009-0974-2","article-title":"Laboratory reproducibility of biochemical markers of bone turnover in clinical practice","volume":"21","author":"Schafer","year":"2010","journal-title":"Osteoporos. Int."},{"issue":"8","key":"10.1016\/j.schres.2015.12.007_bb0180","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/clinchem\/47.8.1443","article-title":"Interlaboratory variation of biochemical markers of bone turnover","volume":"47","author":"Seibel","year":"2001","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.schres.2015.12.007_bb0185","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3949\/ccjm.75.10.739","article-title":"Using biochemical markers of bone turnover in clinical practice","volume":"75","author":"Singer","year":"2008","journal-title":"Cleve. Clin. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2015.12.007_bb0190","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.33549\/physiolres.931858","article-title":"Nutrition as prevention and treatment of osteoporosis","volume":"58","author":"Stransky","year":"2009","journal-title":"Physiol. Res."},{"issue":"6","key":"10.1016\/j.schres.2015.12.007_bb0195","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/acps.12313","article-title":"A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia","volume":"130","author":"Stubbs","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.schres.2015.12.007_bb0200","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.genhosppsych.2015.01.004","article-title":"Schizophrenia and the risk of fractures: a systematic review and comparative meta-analysis","volume":"37","author":"Stubbs","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2015.12.007_bb0205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/hup.1250","article-title":"No association between bone mass and prolactin levels among patients with schizophrenia","volume":"26","author":"Sugawara","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.schres.2015.12.007_bb0210","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2015"},{"issue":"2","key":"10.1016\/j.schres.2015.12.007_bb0215","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.schres.2015.12.007_bb0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1479-5876-11-201","article-title":"The clinical utility of bone marker measurements in osteoporosis","volume":"11","author":"Wheater","year":"2013","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.schres.2015.12.007_bb0225","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2015.12.007_bb0230","doi-asserted-by":"crossref","first-page":"167138","DOI":"10.1155\/2013\/167138","article-title":"Osteoporosis associated with antipsychotic treatment in schizophrenia","volume":"2013","author":"Wu","year":"2013","journal-title":"Int. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.schres.2015.12.007_bb0235","first-page":"134","article-title":"Osteoporosis risk factors among patients with schizophrenia","volume":"63","author":"Wyszogrodzka-Kucharska","year":"2006","journal-title":"Przegl. Lek."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415300803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415300803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T19:17:38Z","timestamp":1718306258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996415300803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":43,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0920996415300803"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.12.007","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}